Camargo

NOVEMBER 11, 2020

Each month, Camargo’s “In the News” series highlights important changes and advancements in the regulatory and development space and explores how those changes could impact your program. Presumably, Antares’ long-established 90-person urology sales force can achieve pull-thru of this drug product. Manager of Regulatory Compliance.

Development 242

Development Bioequivalency Generic Drugs Production 242

pharmaphorum

NOVEMBER 26, 2020

Marketing agency VMLY&R has launched a new global healthcare agency, VMLY&Rx, to service specialty prescription pharmaceutical companies developing innovative breakthrough therapies. The post VMLY&R creates global healthcare agency for innovative pharma companies appeared first on.

Pharma Companies 52

Pharma Companies Marketing Development Branding 52

pharmaphorum

AUGUST 24, 2020

Takeda has joined the ranks of big pharma companies jettisoning consumer health businesses in order to concentrate on higher-margin prescription drugs. Takeda Consumer Healthcare sells OTC medicines and other health products with sales of 60 billion yen ($567 million) in fiscal 2019.

Sales 64

Sales Medicine Production Pharma Companies 64

World of DTC Marketing

SEPTEMBER 7, 2022

In pharma, growth depends on new products with hefty price tags when over 80% of voters want lower costs for their prescription drugs. Biogen’s failure should be a warning to other pharma companies. Now Biogen is a shell of a company selling off assets to survive. It should be a warning to other pharma companies.

Pharma Companies 210

Pharma Companies Drugs Marketing Production 210

pharmaphorum

SEPTEMBER 30, 2021

The acute demands on today’s healthcare systems require ever-more effective learning opportunities for healthcare professionals (HCPs) and offer pharma companies valuable chances to support evidence-based clinical practice. Ways for pharma to support case-based content. Medical education doesn’t stand still.

Development 98

Development Pharma Companies Sales Research 98

pharmaphorum

MARCH 11, 2022

After a period where vaccine development had fallen away, suddenly it is back in the limelight. However, for those individuals working on vaccine development, the pandemic has proven to be a validation of the important work being carried out in the field. There are very few things to be grateful for about the arrival of the pandemic.

Vaccination 81

Vaccination Vaccine Development Manufacturing 81

Roots Analysis

FEBRUARY 27, 2024

This is expected to create immense problems across developing countries with the likely exception of India and China. However, some of the pharma companies fared relatively well. Especially big Pharma players, such as Amgen, Pfizer, and BMS demonstrated high single-digit growth in sales during the recession.

Pharma Companies 52

Pharma Companies Sales Development Marketing 52

pharmaphorum

FEBRUARY 26, 2021

Centessa’s founder on the new company’s unique R&D model. Putting together a quarter-billion dollar pharma company from ten mergers in four months is not for the faint-hearted – but that’s what biotech investment guru Francesco de Rubertis has achieved with his latest project Centessa. Digitalising drug discovery.

Development 59

Development Research Pharma Companies Vaccination 59

World of DTC Marketing

APRIL 5, 2022

What is the definition of a successful pharma product launch? Usually, it’s reaching a certain sales level within a specified time, but that metric is not relevant anymore. Pharma companies have been investing deeply into digital advertising but vastly under measuring customer engagement and other metrics.

Production 196

Production Pharma Companies Branding Marketing 196

Pharmaceutical Technology

SEPTEMBER 2, 2022

Yet despite this promising data, it’s a well-known fact that drug launches are under-performing – with around two-thirds of new drugs successfully navigating the long and rocky approval process only to fall drastically short of their pre-launch sales expectations. De-risking drug launch.

Drugs 130

Drugs Pharma Companies Medicine Production 130

World of DTC Marketing

APRIL 23, 2021

The politics of working with a major pharma company can be a difficult challenge. There is still much to emphasis on doing things that deliver sales rather than helping patients. I’m surprised that an agency hasn’t developed an app to monitor social media posts around certain keywords for pharma.

Pharma Companies 188

Pharma Companies Doctors Doctor Marketing 188

World of DTC Marketing

APRIL 6, 2022

Pharma companies are increasing digital budgets, but they are wasting too much money because of internal staffing issues and inexperience with online marketing. Pharma DTC marketers should develop personas for their target audience that tells us who they are like: 1ne: Where do they go for medical information online?

Marketing 196

Marketing Sales Pharma Companies Doctor 196

Pharmaceutical Technology

SEPTEMBER 2, 2022

Since the frontline treatment setting is dominated by these regimens, pharma companies have focused on the development of new drugs in the relapsed/refractory (R/R) setting. billion global sales expected by 2028, followed by Tecvayli with $2.6bn, which would mark a huge win for J&J in the MM space.

Antibody 147

Antibody Sales FDA Approval Production 147

XTalks

MAY 29, 2024

The top ten pharma companies in 2023 by revenue accounted for about 35 percent of the market value, with total earnings of $559.5 The top big pharma players have remained relatively consistent in their market positions over the past several years. Here is a look at the top ten pharma companies in 2024 based on 2023 revenue.

Pharma Companies 52

Pharma Companies Sales FDA Approval Vaccination 52

World of DTC Marketing

JANUARY 10, 2022

Pharma companies are flush with cash and looking to make deals, but there are still a lot of small biotech companies that don’t have enough money to launch their products entirely. billion, which was much lower than previous studies, which have placed the average cost of drug development as $2.8 million $1228.9

Production 213

Production Drugs Development Marketing 213

Pharmaceutical Technology

AUGUST 30, 2022

International companies investing in the emerging market of Brazilian pharmaceutical manufacturing will see a higher return on investment than from developed market equivalents, if they choose to compete with local manufacturers to supply Brazil’s growing market and the greater South American region.

Manufacturing 195

Manufacturing Marketing Pharma Companies Vaccination 195

Pharma Marketing Network

OCTOBER 1, 2024

Introduction to Pharma Marketing Strategies Pharma marketing strategies encompass a range of activities aimed at promoting pharmaceutical products to healthcare professionals and consumers. These strategies are designed to increase brand awareness, educate the target audience, and ultimately drive sales.

Marketing 52

Marketing Pharma Companies Regulation Production 52

Pharmaceutical Technology

AUGUST 1, 2022

Since 2020, government agencies have provided funding for expensive late-stage vaccine development and the expansion of manufacturing capacity, as well as other key pharmaceutical activities. The shift from private to public funding enabled more rapid development of Covid-19 drugs and vaccines.

Vaccination 234

Vaccination Vaccine Bacteria Life Science 234

pharmaphorum

JANUARY 19, 2021

A new survey highlights the importance of customer reference data to digital transformation and analyses ways pharma companies can improve the quality of their datasets. More pharma companies are moving in this direction, and 78% of respondents said they are undertaking, or planning, a customer data enhancement initiative.

Pharma Companies 87

Pharma Companies Sales Life Science Production 87

World of DTC Marketing

DECEMBER 21, 2020

Long after COVID is a bad memory, the pharma industry will still be making more and more mistakes in the name of profits. I keep talking to pharma old-timers who talk about the “good old days” of working in an industry when sales, and profits, were instrumental in every decision we made.

Pharma Companies 180

Pharma Companies Sales Marketing Vaccine 180

World of DTC Marketing

NOVEMBER 16, 2021

They expect and want more from HCPs and pharma companies. The medical industry is shifting from a model that revolves around sales reps to an omnichannel world in which HCPs are able to access information as and when they need it. Omnichannel marketing, for example, depends on the audience size and the message development.

Marketing 253

Marketing Doctor Doctors Sales 253

Pharma Marketing Network

OCTOBER 28, 2023

It is a shift from a traditional focus on drug development and marketing to a focus on the patient’s needs. This shift is being driven by advances in digital communication, which are allowing companies to better understand and meet the needs of their patients. What is Patient-Centricity?

Pharma Companies 52

Pharma Companies Marketing Development Sales 52

Pharma Marketing Network

OCTOBER 14, 2024

Among these, influencer marketing has emerged as a powerful tool for pharma companies seeking to build trust and foster engagement with their target audiences. Unlike mainstream social media influencers, those in the pharma sector often have smaller but highly engaged audiences that value their professional opinions and insights.

Marketing 52

Marketing Branding Pharma Companies Production 52

World of DTC Marketing

APRIL 14, 2021

One of the biggest problems with a system that directs medical research towards profits rather than needs is that R&D funding is channelled to those products that can make pharma companies the most money. How do pharma industry supporters justify a system that denies affordable drugs to billions of people?

Pharma Companies 191

Pharma Companies Vaccination Vaccine Sales 191

Pharmaceutical Technology

JULY 21, 2022

Pharma giant AstraZeneca also plans to make its supply chain carbon-negative by 2030; to reduce its Scope 1 emissions by 20%, Scope 2 emissions by 95%, and Scope 3 emissions by 25% per $1m of sales by 2025. Access to medication. Improving access could save ten million lives each year, four million in Africa and Southeast Asia.

Pharma Companies 130

Pharma Companies Clinical Trials Drugs Clinical Trials 130

Pharmaceutical Technology

NOVEMBER 25, 2022

Pharmaceutical companies are looking to paediatric indications of approved adult dosage forms (ADFs) to sustain and fuel growth. But the challenges for drug producers developing PDFs are numerous and varied. PDF scale and reformulation challenge manufacturers.

Manufacturing 130

Manufacturing Production Pharma Companies Development 130

pharmaphorum

NOVEMBER 29, 2021

The UK’s Vaccines Manufacturing and Innovation Centre (VMIC) – unveiled with fanfare by the government in 2018 – is rumoured to be up for sale. It was billed at the time as a key tool to accelerate the development of new and innovative vaccines to combat some of the world’s most prevalent diseases, from discovery to licensed product.

Vaccination 100

Vaccination Vaccine Manufacturing Pharma Companies 100

pharmaphorum

MAY 13, 2021

Virtual communications between sales reps and HCPs jumped significantly during 2020, making it more important than ever for pharma companies to maintain up-to-date customer data. Unfortunately, an average of 20% of a company’s self-maintained data is often found to be inaccurate. Make it easy for the sales team.

Life Science 92

Life Science Sales Pharma Companies Production 92

pharmaphorum

SEPTEMBER 20, 2021

For the pharma industry, the pandemic’s changes were both abrupt and industry-altering, requiring companies to rapidly adapt their approaches to drug development and commercialisation. Analytics tools managed by the pharma sales team can be valuable for tracking physician preferences when developing your omnichannel approach.

Sales 97

Sales Marketing Pharma Companies Licensing 97

pharmaphorum

FEBRUARY 12, 2021

The deal covers global rights to three brands – Zinnat (cefuroxime axetil), Zinacef (cefuroxime) and Fortum (ceftazidime) – which are sold in more than 100 markets around the world and had sales of around $140 million last year.

Drugs 111

Drugs Sales Marketing Pharma Companies 111

pharmaphorum

APRIL 12, 2022

Separating the amount of antibiotic used from the payment model could entice pharma companies – who have abandoned antimicrobial R&D in their drives in the last decades – to enter the category once again and help to develop new drugs that will tackle the pressing issue of antimicrobial resistance (AMR).

Pharma Companies 118

Pharma Companies Development Drugs Medicine 118

pharmaphorum

FEBRUARY 14, 2022

The easy answer as to why this has happened can be quickly linked to the COVID-19 pandemic, where sales of vaccines and treatments led to a large increase in return on investment and sales projections. As a result, the estimated peak sales of assets increased from $360 million to $521 million in 2019 and 2021, respectively.

Production 98

Production Clinical Trials Clinical Trials Sales 98

World of DTC Marketing

JANUARY 7, 2021

Some within pharma has worked at so many jobs their resume reads like a list of pharma companies. These people tend to want titles of importance and come across as someone who would politically fit within a company. Do they feel their job is done with the development of the vaccine?

Pharma Companies 215

Pharma Companies HR Vaccination Vaccine 215

pharmaphorum

MARCH 5, 2021

The European Commission has formally opened an antitrust investigation into Teva, which will assess whether the pharma company illegally delayed launches and use of generic versions of its blockbuster multiple sclerosis drug Copaxone. In the end it wasn’t enough and sales last year were $213 million, a fraction of the $4.3

Drugs 98

Drugs Sales Pharma Companies Generic Drugs 98

World of DTC Marketing

JANUARY 24, 2022

Venture capitalists have poured $42 billion into drug development over the past three years. Most small biotech companies rely on venture capitalist funding to develop new drugs but is that a good way to go? billion, which was much lower than previous studies, which have placed the average cost of drug development as $2.8

Life Science 225

Life Science Drugs Development Genetic Disease 225

pharmaphorum

DECEMBER 7, 2022

Pharma companies involved in the sale of heartburn therapy Zantac have won a key battle in litigation brought by patients who claim the drug caused them to develop cancer.

Sales 75

Sales Contamination Pharma Companies Drugs 75

pharmaphorum

JANUARY 8, 2021

The global pandemic has caused pharma companies to invest in digital marketing, as healthcare systems across the world adapt to strict lockdown rules. Healthcare companies have been in the vanguard of this change, with an enormous rise in the use of telehealth and all forms of digital communications. Will we go back to that?

Marketing 82

Marketing Doctor Doctors Pharma Companies 82